KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Retained Earnings (2017 - 2025)

Historic Retained Earnings for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$2.9 billion.

  • Guardant Health's Retained Earnings fell 1616.34% to -$2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9 billion, marking a year-over-year decrease of 1616.34%. This contributed to the annual value of -$2.6 billion for FY2024, which is 2037.35% down from last year.
  • Latest data reveals that Guardant Health reported Retained Earnings of -$2.9 billion as of Q3 2025, which was down 1616.34% from -$2.8 billion recorded in Q2 2025.
  • Guardant Health's 5-year Retained Earnings high stood at -$711.8 million for Q1 2021, and its period low was -$2.9 billion during Q3 2025.
  • In the last 5 years, Guardant Health's Retained Earnings had a median value of -$1.9 billion in 2023 and averaged -$1.8 billion.
  • As far as peak fluctuations go, Guardant Health's Retained Earnings plummeted by 8705.44% in 2021, and later plummeted by 1616.34% in 2025.
  • Guardant Health's Retained Earnings (Quarter) stood at -$1.0 billion in 2021, then tumbled by 64.95% to -$1.7 billion in 2022, then decreased by 28.84% to -$2.1 billion in 2023, then fell by 20.37% to -$2.6 billion in 2024, then fell by 11.16% to -$2.9 billion in 2025.
  • Its Retained Earnings was -$2.9 billion in Q3 2025, compared to -$2.8 billion in Q2 2025 and -$2.7 billion in Q1 2025.